Biomeasure Inc

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

General Electric Healthcare in Marlborough, MA is a prominent company specializing in the development and manufacturing of healthcare technologies and solutions. With a focus on innovation and cutting-edge research, the company plays a vital role in advancing medical imaging, diagnostics, and patient care worldwide. Generated from their business information

Dyhydromatics LLC in Acton specializes in providing high shear fluid processors for various industries, including pharmaceutical, biotech, chemical, food, personal care, and cannabis. Their ShearJet technology is designed for particle size reduction, nanoemulsions, nanodispersions, nanoencapsulations, liposomes, and cell disruption, offering solutions for a wide range of processing needs. Generated from their website's infomation